Lexicon Pharmaceuticals, Inc. (LXRX)

Lexicon Pharmaceuticals Revenue

Lexicon Pharmaceuticals had revenue of $28.87M in the quarter ending June 30, 2025, with 1,652.64% growth. This brings the company's revenue in the last twelve months to $58.43M, up 1,504.83% year-over-year. In the year 2024, Lexicon Pharmaceuticals had annual revenue of $31.08M with 2,481.48% growth.

• Revenue (ttm): $58.43M
• Revenue Growth: +1,504.83%
• P/S Ratio: 7.38
• Revenue / Employee: $567,301
• Employees: 103
• Market Cap: 432.44M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	31.08M	29.88M	2,481.48%
Dec 31, 2023	1.20M	1.07M	766.19%
Dec 31, 2022	139.00K	-159.00K	-53.36%
Dec 31, 2021	298.00K	-23.70M	-98.76%
Dec 31, 2020	24.00M	-298.08M	-92.55%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.